Koninklijke Philips (NYSE:PHG) Given Consensus Rating of “Hold” by Analysts

 In Uncategorized

Shares of Koninklijke Philips (NYSE:PHGGet Rating) have received a consensus rating of “Hold” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $31.90.

PHG has been the subject of a number of research analyst reports. Credit Suisse Group cut their target price on shares of Koninklijke Philips from €32.50 ($34.57) to €31.00 ($32.98) in a research report on Monday, March 28th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Koninklijke Philips from €35.00 ($37.23) to €30.00 ($31.91) and set a “hold” rating for the company in a research report on Monday, March 28th. AlphaValue lowered shares of Koninklijke Philips to a “buy” rating in a research note on Wednesday, March 23rd. Zacks Investment Research upgraded shares of Koninklijke Philips from a “sell” rating to a “hold” rating and set a $26.00 price target on the stock in a research note on Tuesday, May 17th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Koninklijke Philips from €29.20 ($31.06) to €26.50 ($28.19) and set a “neutral” rating on the stock in a research note on Tuesday, April 26th.

Shares of NYSE:PHG opened at $25.12 on Tuesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.93 and a current ratio of 1.39. The company has a market cap of $22.74 billion, a PE ratio of 6.08, a price-to-earnings-growth ratio of 1.27 and a beta of 0.92. Koninklijke Philips has a 52 week low of $23.07 and a 52 week high of $57.65. The firm has a 50 day simple moving average of $28.34 and a 200 day simple moving average of $33.02.

Koninklijke Philips (NYSE:PHGGet Rating) last released its earnings results on Monday, April 25th. The technology company reported $0.32 earnings per share (EPS) for the quarter. Koninklijke Philips had a net margin of 19.56% and a return on equity of 9.19%. The company had revenue of $4.29 billion during the quarter. On average, equities analysts predict that Koninklijke Philips will post 1.75 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of PHG. Wellington Management Group LLP grew its position in Koninklijke Philips by 88.2% in the 3rd quarter. Wellington Management Group LLP now owns 7,050,676 shares of the technology company’s stock worth $313,332,000 after purchasing an additional 3,303,565 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Koninklijke Philips by 59.6% during the 1st quarter. BlackRock Inc. now owns 4,430,980 shares of the technology company’s stock worth $135,277,000 after acquiring an additional 1,655,150 shares during the period. Thompson Siegel & Walmsley LLC bought a new position in shares of Koninklijke Philips during the 1st quarter worth about $50,119,000. Pendal Group Ltd bought a new position in shares of Koninklijke Philips during the 1st quarter worth about $41,513,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Koninklijke Philips by 476.3% during the 1st quarter. Renaissance Technologies LLC now owns 1,283,821 shares of the technology company’s stock worth $39,289,000 after acquiring an additional 1,061,054 shares during the period. Institutional investors own 14.84% of the company’s stock.

Koninklijke Philips Company Profile (Get Rating)

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.

Featured Articles

Analyst Recommendations for Koninklijke Philips (NYSE:PHG)

DefenseWorld source|articles

Favorite 0

Start typing and press Enter to search